SCHEMBL19475136

SCHEMBL19475136

CC(=O)Nc1c(C)ccnc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.45
PKM P14618 1/20 0.45
ALDH1A1 P00352 4/20 0.42
HPGD P15428 2/20 0.40
PTPRB P23467 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA12 O43570 1/20 0.38
BRD4 O60885 1/20 0.38
NR1I2 O75469 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MB P02144 1/20 0.38
CYP1A1 P04798 1/20 0.38
CA3 P07451 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16919139 0.85 ALDH1A1 (0.49) GAAPKMALDH1A1HPGDPTPRB
SCHEMBL23234957 0.77 ALDH1A1 (0.43) GAAPKMALDH1A1HPGDPTPRB
SCHEMBL1345232 0.77 GAA (0.42) GAAPKMALDH1A1HPGDPTPRB
SCHEMBL9735288 0.74 TOP2A (0.44) GAAALDH1A1HPGDMEN1KMT2A
SCHEMBL15564197 0.74 L3MBTL1 (0.54) GAAPKMALDH1A1HPGDPTPRB
SCHEMBL3921054 0.74 TRPV1 (0.51) MEN1KMT2AMAPT
SCHEMBL29105511 0.73 KMT2A (0.44) ALDH1A1KMT2AMAPTPOLBKDM4E
SCHEMBL30589715 0.73 KMT2A (0.44) ALDH1A1KMT2AMAPTPOLBKDM4E
SCHEMBL10394083 0.73 MAPK14 (0.46) ALDH1A1HPGDKDM4E
SCHEMBL11465233 0.72 LMNA (0.41) GAAALDH1A1HPGDCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311813-B Palladium-catalyzed meta-C-H functionalized universal ligands 斯克利普斯研究院 2023-02-28 CN disclosed
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed
CN-109311813-A The functionalized universal ligand of the meta position-C-H of palladium chtalyst 斯克利普斯研究院 2019-02-05 CN disclosed
WO-2017184589-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-26 WO disclosed
WO-2017184589-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH GAA 3562/4885PKM 2319/4885ALDH1A1 208/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC GAA 2868/4885PKM 2074/4885ALDH1A1 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.